Guided Therapeutics Growth Metrics (2011-2025) | GTHP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)			-0.24M	0.04M		1.37M	-3.82M		0.50M	1.09M			-0.22M			-5.19M				5.33M
EBITDA Margin Growth (3y) (Quarter)		-2.19M	0.91M	0.03M	-0.74M	1.84M	-2.20M					-0.04M				-5.27M		1.37M	4.00M
EBITDA Margin Growth (5y) (Quarter)			-0.18M	-0.10M	-0.64M	-1.37M	-3.67M		0.56M	0.27M		-0.04M	-0.46M			-5.24M			-0.06M	0.10M
EBITDA Margin (QoQ) (Quarter)			2.55M	0.18M	-0.81M	-0.55M	-2.65M			0.04M			-0.45M						-0.02M	0.07M
EBIT Margin Growth (1y) (Quarter)			-0.24M	0.04M		1.37M	-3.82M		0.50M	1.09M			-0.22M			-5.19M				5.33M
EBIT Margin Growth (3y) (Quarter)		-2.19M	0.91M	0.03M	-0.74M	1.84M	-2.20M					-0.04M				-5.27M		1.37M	4.00M
EBIT Margin Growth (5y) (Quarter)			-0.18M	-0.10M	-0.64M	-1.37M	-3.67M		0.56M	0.27M		-0.04M	-0.46M			-5.24M			-0.06M	0.10M
EBIT Margin (QoQ) (Quarter)			2.55M	0.18M	-0.81M	-0.55M	-2.65M			0.04M			-0.45M						-0.02M	0.07M
EBT Margin Growth (1y) (Quarter)			-0.17M	-0.94M		3.32M	-3.71M		0.62M	1.50M			-0.28M			-6.40M				6.50M
EBT Margin Growth (3y) (Quarter)		-9.45M	3.77M	0.58M	-0.89M	24.78M	-2.41M					-0.99M				-6.45M		1.78M	3.55M
EBT Margin Growth (5y) (Quarter)			0.06M	-0.12M	-0.96M	-1.73M	-2.96M		-3.10M	-4.63M		0.53M	-0.55M			-7.20M			-0.33M	-0.89M
EBT Margin (QoQ) (Quarter)			5.21M	-0.11M	-0.94M	-0.84M	-1.82M			0.04M			-0.55M						-0.05M	0.10M
Enterprise Value Growth (1y) (Quarter)	-5,838.10%	-20.84%	6.88%	-253.30%	41.86%	51.63%	-398.52%	-259.72%	-153.38%	-204.48%	72.90%	74.45%	75.78%	79.75%	73.46%	34.35%	74.16%	32.73%	55.15%	83.76%
Enterprise Value Growth (3y) (Quarter)	-154.11%	-182.26%	-97.71%		-394.38%			-37.03%	-343.91%	-21.19%	-7.96%	-48.08%	29.07%	33.19%	28.95%	15.50%	45.87%	25.42%	68.17%	69.91%
Enterprise Value Growth (5y) (Quarter)	-86.01%	-111.09%	-166.83%	-114.99%	-273.31%	-123.49%	-105.27%	-370.80%	-89.09%	-101.38%	-59.87%		-136.61%			15.47%	-40.51%	24.68%	31.60%	19.12%
Enterprise Value (QoQ) (Quarter)	-585.16%	26.06%	41.32%	-18.85%	-12.75%	38.48%	-504.71%	14.24%	20.58%	26.08%	46.17%	19.15%	24.70%	38.20%	29.45%	-100.00%	70.36%	-60.87%	52.97%	27.59%
FCF Margin Growth (1y) (Quarter)			-0.31M	0.16M		2.75M	-1.64M		0.16M	0.63M			0.06M			-3.21M				3.32M
FCF Margin Growth (3y) (Quarter)		-3.18M	1.69M	0.10M	-0.28M	1.15M	0.25M					0.03M				-3.35M		0.72M	1.98M
FCF Margin Growth (5y) (Quarter)				0.02M	-0.19M	-0.75M	-1.97M		0.76M	0.20M		-0.03M	-0.06M			-3.19M			0.03M	0.13M
FCF Margin (QoQ) (Quarter)			3.09M	0.42M	-0.41M	-0.35M	-1.30M			0.13M			-0.06M						-0.03M	0.04M
FCF Payout Ratio Growth (1y) (Quarter)													-399.00%
FCF Payout Ratio (QoQ) (Quarter)														60.77%
Gross Margin Growth (1y) (Quarter)			-0.02M	-0.03M		-0.00M	0.02M		-0.00M	-0.01M			758.00			-0.03M				0.03M
Gross Margin Growth (3y) (Quarter)		0.00M	-0.02M	0.02M	-0.00M	0.65M	0.00M					-0.03M				-0.03M		-0.00M	-0.00M
Gross Margin Growth (5y) (Quarter)			-0.01M	0.00M	0.01M	0.01M	0.03M		0.00M	-0.01M		0.02M	-0.00M			-0.03M			-0.00M	-0.03M
Gross Margin (QoQ) (Quarter)			-0.02M	0.02M	0.00M	0.00M	0.00M			-0.00M			0.00M						-919.00	0.00M
Interest Coverage Ratio Growth (1y) (Quarter)	-592.22%	-48.65%	-69.87%	-120.52%	24.85%	-57.26%	-863.18%	-211.33%	-191.21%	-678.77%	-11.12%	50.26%	56.08%	59.96%	40.80%	40.84%	49.79%	44.35%	27.62%	3.17%
Interest Coverage Ratio Growth (3y) (Quarter)	-55.88%	-2.40%	5.74%	-110.88%	-85.00%	-31.25%	-150.90%	-220.74%	-147.43%	-163.07%	-162.95%	-50.59%	1.32%	-69.89%	-85.04%	2.88%	13.73%	-20.17%	21.92%	34.20%
Interest Coverage Ratio Growth (5y) (Quarter)	3.98%	-19.19%	22.87%	-3.08%	-13.73%	-11.30%	-9.59%	-40.16%	-52.65%	-67.41%	-55.05%	-70.77%	-51.94%	-47.79%	-59.70%	-57.56%	-27.28%	-32.32%	-50.77%	-14.36%
Interest Coverage Ratio (QoQ) (Quarter)	-195.90%	69.49%	53.96%	-430.57%	-0.83%	36.14%	-181.95%	-71.50%	5.69%	-70.77%	59.77%	23.23%	16.73%	-55.69%	40.52%	23.28%	29.33%	-72.56%	22.64%	-2.63%
Net Margin Growth (1y) (Quarter)			-0.23M	-0.93M		3.78M	-3.49M		1.67M	1.65M			-0.29M			-6.85M				6.98M
Net Margin Growth (3y) (Quarter)		-10.02M	3.76M	0.57M	-1.99M	24.53M	-2.25M					-0.99M				-6.92M		1.94M	3.38M
Net Margin Growth (5y) (Quarter)			0.01M	-0.13M	-2.01M	-1.88M	-2.78M		-3.01M	-4.59M		0.51M	-0.61M			-7.68M			-0.33M	-0.87M
Net Margin (QoQ) (Quarter)			5.77M	-0.06M	-2.03M	0.10M	-1.50M			0.08M			-0.59M						-0.06M	0.11M
Operating Margin Growth (1y) (Quarter)			-0.24M	0.04M		1.37M	-3.82M		0.50M	1.09M			-0.22M			-5.19M				5.33M
Operating Margin Growth (3y) (Quarter)		-2.19M	0.91M	0.03M	-0.74M	1.84M	-2.20M					-0.04M				-5.27M		1.37M	4.00M
Operating Margin Growth (5y) (Quarter)			-0.18M	-0.10M	-0.64M	-1.37M	-3.67M		0.56M	0.27M		-0.04M	-0.46M			-5.24M			-0.06M	0.10M
Operating Margin (QoQ) (Quarter)			2.55M	0.18M	-0.81M	-0.55M	-2.65M			0.04M			-0.45M						-0.02M	0.07M
Return on Assets Growth (1y) (Quarter)	-3.00	6.00	2.00	-1.00	1.00	-2.00	-1.00	0.00M	-1.00	-1.00	-1.00	-1.00	0.00M	0.00M	1.00	0.00M	0.00M	-1.00	-1.00	-1.00
Return on Assets Growth (3y) (Quarter)	22.00	15.00	11.00	-4.00	0.00M	18.00	18.00	1.00	-3.00	3.00	-1.00	-2.00	0.00M	-3.00	-2.00	-1.00	-1.00	-2.00	-2.00	-2.00
Return on Assets Growth (5y) (Quarter)	0.00M	3.00	2.00	1.00	2.00	1.00	3.00	18.00	22.00	12.00	9.00	-5.00	-1.00	18.00	17.00	1.00	-3.00	2.00	-2.00	-3.00
Return on Assets (QoQ) (Quarter)	-2.00	3.00	-1.00	-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	0.00M	0.00M	0.01M	0.00M	0.00M	-264.00	0.00M	0.02M	0.04M	0.01M	0.00M	-0.02M	-0.03M	-0.01M	-0.01M	-0.01M	-0.00M	-678.00	-356.00	-61.00
Return on Capital Employed Growth (3y) (Quarter)	-326.00	0.00M	0.01M	0.00M	0.00M	0.00M	0.01M	0.03M	0.04M	0.02M	0.01M	0.01M	0.01M	-412.00	-0.00M	-0.00M	-0.00M	-826.00	-0.01M	-0.02M
Return on Capital Employed Growth (5y) (Quarter)	-0.01M	-0.00M	128.00	0.00M	0.00M	0.00M	0.01M	0.02M	0.04M	0.02M	0.01M	0.01M	0.01M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed (QoQ) (Quarter)	837.00	0.00M	0.00M	-744.00	-291.00	-759.00	0.01M	0.02M	0.02M	-0.02M	-0.01M	-0.00M	-0.00M	-0.00M	-553.00	42.00	222.00	-389.00	-231.00	337.00
Return on Equity Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	1.00	1.00	1.00	1.00	1.00	-1.00	-1.00	-1.00	-1.00	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (3y) (Quarter)	0.00M	-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	2.00	2.00	1.00	1.00	0.00M	1.00	1.00	0.00M	0.00M	0.00M	0.00M	-1.00
Return on Equity Growth (5y) (Quarter)	-1.00	-1.00	-1.00	0.00M	0.00M	0.00M	0.00M	1.00	1.00	1.00	1.00	1.00	1.00	0.00M	0.00M	0.00M	1.00	0.00M	0.00M	1.00
Return on Equity (QoQ) (Quarter)	0.00M	-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Sales Growth (1y) (Quarter)	-91.00	-337.00	-17.00	-94.00	-67.00	332.00	-371.00	-327.00	62.00	150.00	293.00	322.00	-28.00	-22.00	18.00	-640.00	-0.00M	50.00	44.00	650.00
Return on Sales Growth (3y) (Quarter)	-305.00	-944.00	377.00	58.00	-89.00	0.00M	-241.00	-402.00	-96.00	145.00	-95.00	-99.00	-32.00	460.00	-60.00	-645.00	-0.00M	178.00	355.00	332.00
Return on Sales Growth (5y) (Quarter)			6.00	-12.00	-96.00	-173.00	-296.00	-252.00	-310.00	-463.00	299.00	53.00	-55.00	0.00M	69.00	-720.00	-0.00M	173.00	-33.00	-89.00
Return on Sales (QoQ) (Quarter)	-121.00	-482.00	521.00	-11.00	-94.00	-84.00	-182.00	33.00	294.00	4.00	-39.00	62.00	-55.00	10.00	1.00	-595.00	-0.00M	0.00M	-5.00	10.00

Research Tools

Guided Therapeutics Growth Metrics (2011-2025) | GTHP

Create an account

Sign In

Reset Password